Tilray Brands, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Irwin David Simon
- Full Time Employees
- 3,595
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 265 Talbot Street West Leamington ON Canada N8H 5L4
- IPO Date
- Jul 19, 2018
- CIK
- 0001731348
- Website
- tilray.com
- Similar Companies
- Business
- Tilray Brands, Inc. (TLRY) is a global lifestyle consumer products company that researches, cultivates, processes, and distributes medical and adult-use cannabis products; alcoholic and non-alcoholic beverages including craft beers from brands such as Blue Point Brewing Company, Breckenridge Brewery, Green Flash Brewing Company, Redhook Ale Brewery, Shock Top, SweetWater Brewing Company, Widmer Brothers Brewery, Montauk Brewing Company, Alpine Beer Company, and Terrapin Beer Company; hemp-based foods and drinks; energy drinks like HiBall Energy; and wellness products encompassing CBD-infused edibles and other non-combustible cannabis formats. Founded in 2013 and headquartered in New York City with principal operations in Canada including facilities in Nanaimo, British Columbia, the company maintains a global footprint spanning Australia, New Zealand, Latin America including recent approvals in Panama, growing cultivation in Germany and Portugal, and distribution in Europe such as Poland and Italy, alongside U.S. beverage exposure. Tilray serves medical cannabis patients, adult recreational users, and consumer packaged goods markets including craft beer enthusiasts and wellness consumers across its four primary segments of cannabis, beverages, wellness, and distribution. In recent developments, Tilray completed Craft Acquisition II effective September 1, 2024, integrating four additional craft brands and breweries to bolster its beverage portfolio; advanced Project 420 for operational synergies targeting $25 million in cost savings through supply chain optimization, brand investments, and efficiency measures; expanded international medical cannabis access with key regulatory approvals and product launches in Panama, Germany, Italy, and Australia; and launched new products including Delta-9 THC-derived beverages and energy drinks while enhancing distribution networks, particularly in global markets. The company, formed through the 2020 reverse merger with Aphria and subsequent 2023 acquisitions of eight Anheuser-Busch beverage brands for $85 million, continues to diversify beyond cannabis into beverages and wellness amid evolving regulations and market growth. Tilray ranks as the ninth-largest craft beer producer in the U.S. by volume and reports ongoing gross profit increases, with Q2 2025 results showing 29% year-over-year growth to $61 million across all segments.
Company News
Breckenridge Distillery and Southern Glazer's Expand Partnership Across New York and California
Tilray's Rescheduling Rally Keeps Fading -- Where Will the Stock Be if Washington Stalls Again?
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?
By Popular Demand: Tilray Beverages Makes Popsicle Hard Firecracker a Permanent Flavor
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
3 Top Marijuana Stocks to Watch in September 2026
Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves
Tilray Brands Looks Ready For Another Large Short Squeeze Move
BrewDog Wins Big at the 2026 World Beer Awards with a Sweeping Show of Brewing Excellence
Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know
Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?
Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD
Top Canadian Cannabis Stocks to Watch in August 2026
BrewDog Unwraps Its 2026 Advent Calendar
Tilray Medical Welcomes Progress in Germany's Medical Cannabis Framework and Supports Continued Policy Development
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle